Welch & Forbes LLC: WMB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Welch & Forbes LLC on WMB, newest first. How the timeline and the estimate are built.
Welch & Forbes LLC held 4,687 WMB shares at 2026-06-30 per its 13F-HR filed 2026-07-30.
the latest 13F is the newest step
- period ended2026-06-3013F 4,687 sharesChange vs previous 13F -548 shares
<0.01% of the 13F portfolio, value $348,432.
13F-HR 0000105495-26-000003 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 5,235 sharesChange vs previous 13F -350 shares
<0.01% of the 13F portfolio, value $381,003.
13F-HR 0000105495-26-000002 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 5,585 sharesChange vs previous 13F -990 shares
<0.01% of the 13F portfolio, value $335,713.
13F-HR 0000105495-26-000001 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 6,575 sharesChange vs previous 13F -934 shares
0.01% of the 13F portfolio, value $416,527.
13F-HR 0000105495-25-000002 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 7,509 sharesChange vs previous 13F +300 shares
0.01% of the 13F portfolio, value $471,640.
13F-HR 0001085146-25-004501 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 7,209 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $430,810.
13F-HR 0001085146-25-002565 filed by Welch & Forbes LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).